Curcumin spice shown to induce cognitive improvement
Posted by Jim Hanekamp | Posted in Alzheimer's, Brain, Dementia, Hippocampus, Neurogenesis | Posted on 16-09-2009
0
Alzheimer’s disease (AD) is a neurodegenerative disorder that currently affects nearly 5% of people 65-year old and over 30% of those 85-year old. It is now estimated that there are 18−24 million people suffering from AD worldwide, two-thirds of whom are living in developed or developing countries, and this number is expected to reach 34 million by 2025. AD is characterized by the progressive accumulation of amyloid beta peptide (Aβ), neurofibrillary tangles (NFTs) and hyperphosphorylated microtubule-associated tau protein. Many regions involved in memory and learning processes, such as the hippocampus and frontal cortex, show neuron apoptosis several years before clinical signs appear. Today there is no cure for this devastating disease and therefore it is of great interest for researchers to find new drugs that can hinder the disease process. Current drugs on the market improve the function of still intact neurons, but do not inhibit the ongoing degenerative process leading to neuronal cell death. Curcumin, a biologically active component of turmeric (Curcuma longa) is used as a curry spice and herbal medicine for the treatment of inflammatory conditions, cancer, AIDS and other diseases. Epidemical studies in India, where turmeric is used routinely, show that the incidence of AD between the ages of 70 and 79 years is 4.4-fold less than in the USA. Results on mice show that a low dose of curcumin significantly suppressed the inflammation, reduced oxidative damage and plaque burden and decreased the amount of insoluble amyloid. Compared to other antioxidant drugs, such as NSAID or ibuprofen, curcumin had fewer side effects. Evidence suggests that metals are concentrated in the AD brain and curcumin is a chelator which can bind the iron and copper (but not zinc) on beta amyloid, which may be one mechanism potentially contributing to amyloid reduction. In vivo, curcumin may protect cells from the beta amyloid attack and subsequent oxidative stress-induced damage in the antioxidant pathway. The findings of a previous study prove curcumin can induce cognitive improvement by enhancing the cholinergic system and its antioxidant activity. The studies on curcumin are incomplete and there needs to be further investigation of its neuroprotective mechanism.

